Working… Menu

A Phase III Trial Evaluating Fruquintinib Efficacy and Safety in 3+ Line Colorectal Cancer Patients (FRESCO) (FRESCO)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02314819
Recruitment Status : Completed
First Posted : December 11, 2014
Last Update Posted : February 26, 2019
Fudan University
Eighty-One Hospital of People's Liberation Army
Information provided by (Responsible Party):
Hutchison Medipharma Limited